nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls
|
Goff, Donald C. |
|
2005 |
80 |
1 |
p. 45-53 9 p. |
artikel |
2 |
Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: A systematic review of randomized trials
|
Rummel, Christine |
|
2005 |
80 |
1 |
p. 85-97 13 p. |
artikel |
3 |
Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial
|
Miller, Del D. |
|
2005 |
80 |
1 |
p. 33-43 11 p. |
artikel |
4 |
Corrigendum to “Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores” [Schizophrenia Research 71 (1) (2004) 155–165]
|
Lenert, Leslie A. |
|
2005 |
80 |
1 |
p. 135-136 2 p. |
artikel |
5 |
Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial
|
Stroup, Scott |
|
2005 |
80 |
1 |
p. 1-8 8 p. |
artikel |
6 |
Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS)
|
Singh, Swaran P. |
|
2005 |
80 |
1 |
p. 117-130 14 p. |
artikel |
7 |
Early warning signs of relapse following a first episode of psychosis
|
Gleeson, John F. |
|
2005 |
80 |
1 |
p. 107-111 5 p. |
artikel |
8 |
Editorial Board
|
|
|
2005 |
80 |
1 |
p. CO2- 1 p. |
artikel |
9 |
Effects of atypical and typical neuroleptics on anterior cingulate volume in schizophrenia
|
McCormick, Laurie |
|
2005 |
80 |
1 |
p. 73-84 12 p. |
artikel |
10 |
Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia
|
Molina, Vicente |
|
2005 |
80 |
1 |
p. 61-71 11 p. |
artikel |
11 |
Persistent psychoses in first episode patients
|
Manchanda, Rahul |
|
2005 |
80 |
1 |
p. 113-116 4 p. |
artikel |
12 |
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
|
McEvoy, Joseph P. |
|
2005 |
80 |
1 |
p. 19-32 14 p. |
artikel |
13 |
Serum lipid profiles and schizophrenia: Effects of conventional or atypical antipsychotic drugs in Taiwan
|
Huang, Tiao-Lai |
|
2005 |
80 |
1 |
p. 55-59 5 p. |
artikel |
14 |
The CATIE schizophrenia effectiveness trial
|
DeLisi, L.E. |
|
2005 |
80 |
1 |
p. v-vi nvt p. |
artikel |
15 |
The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome
|
Meyer, Jonathan M. |
|
2005 |
80 |
1 |
p. 9-18 10 p. |
artikel |
16 |
The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: A 1-year follow up study
|
Rémillard, Sophie |
|
2005 |
80 |
1 |
p. 99-106 8 p. |
artikel |
17 |
Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders
|
Sengupta, Sarojini M. |
|
2005 |
80 |
1 |
p. 131-133 3 p. |
artikel |